Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Oh hi. Today, we talk about Eli Lilly’s plan to invest $27 billion into new manufacturing sites stateside, learn about a new wave of biotech VCs, and more.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in